Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 35%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a strong player in the household and personal care industry, with international sales accounting for 70% of its business. Despite macro pressures and a slower start in North America, the company has a consistent track record of delivering within or above its targeted range of +3-5% for organic sales growth. While there may be some potential gross risk for 2026E EPS due to rising resin and oil-derived costs, we believe Colgate-Palmolive has the ability to mitigate this through productivity increases, pricing adjustments, and other measures. Overall, we are optimistic about the company's potential for consistent revenue growth and gains in market share in the long term.

Bears say

Colgate-Palmolive is facing several headwinds in the near-term, including FX headwinds, a potential decline in private label pet food sales, and a challenging industry landscape. The company's sustainability initiatives may help mitigate some risks, but its 2026-2028 organic sales and EPS growth targets are modest. Overall, our outlook remains negative for the stock due to potential challenges in the industry and the company's limited growth potential.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 35% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.